Hypertension in hypophosphatemic rickets - Role of secondary hyperparathyroidism

Pediatric Nephrology

Volumn 18, Issue 2, 2003, Pages 155-158

  Alon, Uri S ^a   Monzavi, Roshanak ^b   Lilien, Marc ^c   Rasoulpour, Majid ^d   Geffner, Mitchell E ^e   Yadin, Ora ^b  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b MATTEL CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d Farmington   (United States)

^e CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Calcium; Nephrocalcinosis; Parathyroid hormone; Phosphate; Vitamin D

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PHOSPHATE; VITAMIN D DERIVATIVE; CREATININE; VITAMIN D;

ADOLESCENT; ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOPPLER FLOWMETRY; ECHOCARDIOGRAPHY; FEMALE; HUMAN; HYPERPARATHYROIDISM; HYPERTENSION; HYPOPHOSPHATEMIA; LABORATORY TEST; MALE; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RICKETS; SCHOOL CHILD; BLOOD; CHEMICALLY INDUCED DISORDER; CHILD; KIDNEY CALCIFICATION; SECONDARY HYPERPARATHYROIDISM;

ADOLESCENT; ADULT; CHILD; CREATININE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; HYPERTENSION; HYPOPHOSPHATEMIA, FAMILIAL; MALE; NEPHROCALCINOSIS; PHOSPHATES; VITAMIN D;

EID: 0043288824     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-002-1044-6     Document Type: Article

References (26)

1. Harrison HE, Harrison HC (1979) Disorders of calcium and phosphate metabolism in childhood and adolescence. Saunders, Philadelphia, pp 100-140
2. Chan JCM, Alon U, Hirshman GM (1985) Renal hypophosphatemic rickets. J Pediatr 106:533-544
3. Latta K, Hisano S, Chan CM (1993) Therapeutics of X-linked hypophosphatemic rickets. Pediatr Nephol 7:744-748
4. Goodyear PR, Kronick JB, Jequier S, Reade TM, Scribver CR (1987) Nephrocalcinosis and its relationship to treatment of hereditary rickets. J Pediatr 111:700-704
5. Verge CF, Lam A, Simpson JM, Cowell CT, Howard NJ, Silink M (1991) Effects of therapy X-linked hypophosphatemic rickets. N Engl J Med 325:1843-1848
6. Alon US (1997) Nephrocalcinosis. Curr Opin Pediatr 9:160-165
7. Nehgme R, Fahey JT, Smith C, Carpenter TO (1997) Cardiovascular abnormalities in patients with X-linked hypophosphatemia. J Clin Endocrinol Metab 82:2450-2454
8. Rivkees SA, El-Hajj-Fuleihan G, Brown EM, Crawford JD (1992) Tertiary hyperparathyroidism during high phosphate therapy of familial hypophosphatemic rickets. J Clin Endocrinol Metab 75:1514-1518
9. Alon U, Lovell HB, Donaldson DL (1992) Nephrocalcinosis, hyperparathyroidism, and renal failure in familial hypophosphatemic rickets. Clin Pediatr (Phila) 31:180-183
10. Wu CJ, Song YM, Sheu WH (2000) Tertiary hyperparathyroidism in X-linked hypophosphatemic rickets. Intern Med 39:468-471
11. Rasoulpour M (18 December 2001) Hypertension in X-linked hypophosphatemia. https://listhost.uchicago.edu/mailman/list-info/pedneph
12. Lilien M (19 December 2001) Hypertension in X-linked hypophosphatemia. https://listhost.uchicago.edu/mailman/listinfo/pedneph
13. Filler G (3 January 2002) Hypertension in X-linked hypophosphatemia. https://listhost.uchicago.edu/mailman/listinfo/pedneph
14. (1996) Update on the 1987 Task Force report on high blood pressure in children and adolescents: a working group report from the National High Blood Pressure Education Program. Pediatrics 98:649-657
15. Davies M (1992) Primary hyperparathyroidism: Aggressive or conservative treatment? Clin Endocrinol (Oxf) 36:325-332
16. Stefenelli T, Abela C, Frank H, Koller-Strametz J, Globits S, Bergler-Klein J, Niederle B (1997) Cardiac abnormalities in patients with primary hyperparathyroidism: Implications for follow-up. J Clin Endocrinol Metab 82:106-112
17. Rastad J, Lundgren E, Ljunghall (2001) Clinical presentation of primary hyperparathyroidism. In: Bilezikian JP, Marcus R, Levine ME (eds) The parathyroids, basic and clinical concepts, 2nd edn. Academic Press, San Diego, pp 361-374
18. Mailloux LU, Levey AS (1998) Hypertension in patients with chronic renal disease. Am J Kidney Dis.32 (Suppl 3]:S120-S141
19. Rostand SG, Drüeke TB (1999) Parathyroid hormone, vitamin D. and cardiovascular disease in chronic renal failure. Kidney Int 56:383-392
20. Massfelder T, Taesch N, Fritsch S, Eichinger A, Barthelmebs M, Stewart A, Helwig JJ (2002) Type 1 parathyroid hormone receptor expression level modulates renal tone and plasma renin activity in spontaneously hypertensive rat. J Am Soc Nephrol 13:639-648
21. Vered I, Vered Z, Perez JE, Jaffe AS, Whyte MP (1990) Normal left ventricular performance in children with X-linked hypophosphatemic rickets: a doppler echocardiography study. J Bone Miner Res 5:469-474
22. Downing JG, Egelhoff JC, Daily DK, Thomas MK, Alon U (1992) Kidney function in very low birthweight infants with furosemide-related renal calcifications at age 1-2 years. J Pediatr 120:599-604
23. Alon US, Scagliotti D, Garola R (1994) Nephrocalcinosis and nephrolithiasis in infants with congestive heart failure treated with furosemide. J Pediatr 125:149-151
24. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP (2002) 1,25- Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110:229-238
25. Blydt-Hansen TD, Tenenhouse HS, Goodyer P (1999) PHEX expression in parathyroid gland and parathyroid hormone dysregulation in X-linked hypophosphatemia. Pediatr Nephrol 13:607-611
26. Rronenberg HM (2002) NPT2a-the key to phosphate homeostasis. N Engl J Med 347:1022-1024